However, this finding was different from a few studies, which found that APPL1 was highly expressed in cholangiocarcinoma (CHOL), liver hepatocellular carcinoma (LIHC), stomach adenocarcinoma (STAD), and breast cancer. This evidence concerns the gene APPL1 and gastric adenocarcinoma.